D5BL:F:F-Xtrackers - MSCI Europe Value UCITS ETF (EUR)

ETF | Others |

Last Closing

USD 34.88

Change

+0.19 (+0.55)%

Market Cap

N/A

Volume

N/A

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-04-24 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
SXR8:F iShares Core S&P 500 UCITS ETF..

N/A

USD 101.74B
UIM5:F UBS (Lux) Fund Solutions - MSC..

+0.19 (+0.39%)

USD 101.37B
ZPDJ:F SPDR® MSCI Japan UCITS ETF

+0.21 (+0.40%)

USD 96.03B
XDNY:F Xtrackers MSCI Japan ESG Scree..

N/A

USD 57.02B
XJSE:F Xtrackers II - Japan Governmen..

-0.01 (-0.13%)

USD 53.72B
VUSA:F Vanguard Funds Public Limited ..

+3.76 (+4.30%)

USD 51.63B
SXRZ:F iShares VII PLC - iShares Nikk..

+0.70 (+0.32%)

USD 45.80B
0ZC:F Zscaler Inc

-0.78 (-0.44%)

USD 37.92B
BSND:F Danone SA

+0.10 (+0.70%)

USD 33.83B
VGWL:F Vanguard FTSE All-World UCITS ..

+3.70 (+3.23%)

USD 24.77B

ETFs Containing D5BL:F

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 7.21% 88% B+ 78% C+
Dividend Return N/A N/A N/A N/A N/A
Total Return 7.21% 88% B+ 77% C+
Trailing 12 Months  
Capital Gain 11.37% 84% B 72% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 11.37% 82% B 64% D
Trailing 5 Years  
Capital Gain 107.10% 93% A 79% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return 107.10% 93% A 62% D
Average Annual (5 Year Horizon)  
Capital Gain 13.84% 84% B 73% C
Dividend Return 13.84% 81% B- 65% D
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 12.79% 52% F 85% B
Risk Adjusted Return 108.20% 94% A 95% A
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike